EXXOGEN is a DeepTech biotechnology startup redefining molecular recognition through a novel, first-principles (ab initio) analytical framework for quantum-level interactions.
Embedded Files
Core Breakthrough: Bypassing iterative Density Functional Theory (DFT) approximations and supercomputer overhead, EXXOGEN utilizes a novel, proprietary analytical operator derived from fundamental quantum principles. Rather than repackaging existing open-source engines, the proprietary operator computes the quantum-level dynamics in the background, outputting the structured and refined energy matrix as seen in the benchmark datasets, delivering near instantaneous computation and massive scalability.
1D66 GAL4–DNA
Benchmark Validation: Testing against the GAL4–DNA complex (PDB: 1D66) demonstrated precise structural mapping and high-fidelity energy state correlation with published crystallographic and biophysical data.M
Testing across independent molecular structures (1D66 and 1H9E) proves that our equation is not data-fitted overfitting, but a universal, molecule-invariant physical law. Identical quantized energy eigenvalues and sub-percent convergence emerged across completely different systems.
Biomolecular Applications: Validated on metagenomic structural datasets (e.g., ESMAtlas MGYP001563787740),The model successfully captured periodic energetic behavior corresponding to the ideal 3.6 residue/turn alpha-helical periodicity, revealing structural energy oscillations and salt-bridge stabilization patterns critical for biophysical resilience.
MGYP001563787740
Scalability & High-Throughput Computation: Automated pipeline capable of generating full interaction maps for massive macromolecular complexes. Successfully processed the complete Titin structure (UniProt Q8WZ42), mapping over 1,000,000 discrete quantum interaction vectors (140 MB dataset). Reference:
EXXOGEN quantum benchmark sample v1.0 (10 molecules) – available on GitHub
Primary Target Markets: Molecule & Biologics Discovery, Rational Enzyme Engineering. Secondary/Future Applications: Bio-compatible materials and structural biophysics.
Current Stage: Early-stage DeepTech R&D (Analytical framework validated). Seeking strategic R&D partnerships, academic/industrial testing collaborations, and Pre-Seed/Seed investment in DeepTech, Computational Chemistry, and Biotech.
"We don't search databases - we calculate reality."
1AON
1AON SIDE VIEW
TITIN Q8WZ42
Follow for more!
Kis Norbert Levente / Founder
All visual data and molecular models are directly generated from EXXOGEN outputs.
© 2026 EXXOGEN. All rights reserved.
Page updated
Google Sites
Report abuse